PDF herunterladen
Thromb Haemost 1985; 54(02): 559
DOI: 10.1055/s-0038-1657906
Letter to the Editor
Schattauer GmbH Stuttgart

Biological Properties of Recombinant and of Natural Pro-Urokinase-Reply

D Collen
Center for Thrombosis and Vascular Research, Department of Medical Research, University of Leuven, Belgium
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 30. November 1984

Accepted 18. Juni 1985

Publikationsdatum:
18. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Zamarron C, Lijnen HR, Van Hoef B, Collen D. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Thromb Haemostas 1984; 52: 19-23
    PubMedGoogle Scholar
  • 2 Collen D, De Cock F, Lijnen HR. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys. Thromb Haemostas 1984; 52: 24-26
    PubMedGoogle Scholar
  • 3 Collen D, Stassen JM, Blaber M, Winkler M, Verstraete M. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis. Throm Haemostas 1984; 52: 27-30
    PubMedGoogle Scholar
  • 4 Lijnen HR, De Wreede K, Demarsin E, Collen D. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. IV. Variability in fibrinolytic response of plasma of several mammalian species. Thromb Haemostas 1984; 52: 31-33
    PubMedGoogle Scholar
  • 5 Wun TC, Ossowski L, Reich E. A proenzyme form of human urokinase. J Biol Chem 1982; 257: 7262-7268
    PubMedGoogle Scholar
  • 6 Nielsen LS, Hansen JG, Skriver L, Wilson EL, Kaltoft K, Zeuthen J, Dano K. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 1982; 21: 6410-6415
    CrossrefPubMedGoogle Scholar
  • 7 Husain S, Gurewich V, Lipinski B. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine. Arch Biochem Biophys 1983; 220: 31-38
    CrossrefPubMedGoogle Scholar
  • 8 Sumi H, Toki N, Sasaki K, Mihara H. Comparative properties of single and double polypeptide chains of high molecular weight urokinase. In: Progress in Fibrinolysis. Vol. VI 165-167 Davidson JF, Bachmann F, Bouvier CA, Kruithof EKO. (eds). Churchill Livingstone; Edinburgh: 1983
    Google Scholar
  • 9 Nolan C, Hall LS, Barlow GH, Tribby IIE. Plasminogen activator from human embryonic kidney cell cultures. Evidence for a proactivator. Biochim Biophys Acta 1977; 496: 384-400
    CrossrefPubMedGoogle Scholar
  • 10 Bernik MB. Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. J Clin Invest 1973; 52: 823-834
    CrossrefPubMedGoogle Scholar
  • 11 Gurewich V, Pannell R, Louie S, Kelley P, Suddith RL, Greenlee R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest 1984; 73: 1731-1739
    CrossrefPubMedGoogle Scholar